Advisornet Financial’s Insys Therapeutics, Inc. INSY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-215
Closed 2033
2019
Q2
$0 Buy
215
+100
+87% +$270 ﹤0.01% 1853
2019
Q1
$1K Hold
115
﹤0.01% 1564
2018
Q4
$0 Hold
115
﹤0.01% 1628
2018
Q3
$1K Hold
115
﹤0.01% 1445
2018
Q2
$1K Hold
115
﹤0.01% 1548
2018
Q1
$1K Buy
+115
New +$950 ﹤0.01% 1388

Advisornet Financial's INSY Position: Q3 2019 in Review

Advisornet Financial sold out of Insys Therapeutics, Inc. (INSY) in Q3 2019, closing a stake of 215 shares.

Advisornet Financial first reported a position in INSY in Q1 2018 and held it in 6 quarters. The position peaked at $1K in Q1 2019. 4 funds tracked by Wall St. Rank hold INSY as of Q3 2019.

  • Advisornet Financial reported no remaining Insys Therapeutics, Inc. position as of Q3 2019 after selling out during the quarter.
  • Advisornet Financial sold 215 Insys Therapeutics, Inc. shares in Q3 2019.
  • Advisornet Financial first reported a position in Insys Therapeutics, Inc. in Q1 2018 and held it in 6 quarters.
  • Advisornet Financial's Insys Therapeutics, Inc. position peaked at $1K in Q1 2019.
  • 4 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q3 2019.

Based on Advisornet Financial's 13F filing for Q3 2019, filed 23 Oct 2019.